ANI Pharmaceuticals Q1 Adj. EPS $2.05 Beats $1.30 Estimate, Sales $237.462M Beat $207.565M Estimate.
ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. ANIP | 0.00 |
ANI Pharmaceuticals (NASDAQ:
ANIP) reported quarterly earnings of $2.05 per share which beat the analyst consensus estimate of $1.30 by 56.49 percent. This is a 20.59 percent increase over earnings of $1.70 per share from the same period last year. The company reported quarterly sales of $237.462 million which beat the analyst consensus estimate of $207.565 million by 14.40 percent. This is a 20.46 percent increase over sales of $197.122 million the same period last year.